Ultrasound in Obstetrics and Gynecology
By Jiri Sonek, January 17, 2021. M.U. is a 32-year-old G2 P1 Caucasian female, who presented at 13 weeks’ gestation by LMP for first trimester combined screening. [Read More...]
BioFluidica Presents at AACR 2019
April 1, 2019. BioFluidica presented at the AACR Conference in Atlanta, GA, April 2019 the following abstracts, "A Non-invasive Diagnostics to Detect Circulating Leukemic Cells in Blood. [Read More...]
Market Intel: Liquid Biopsy-Ready For Prime Time?
MedTech Insight | Bob Kronemyer, March 12, 2019 San Diego, California-based BioFluidica Inc. developed the Liquid Scan microfluidic chip that can both monitor and detect circulating tumor [Read More...]
BioFluidica Presents at Molecular Med TRI-CON
March 10, 2019 BioFluidica presented at the Molecular Med Tri-Conference in San Francisco, CA, March 2019 the following abstracts, "Detection of CTCs from Whole Blood of Lung [Read More...]
BioFluidica CoFounder and CTO, Stephen Soper, on Facebook Live: Bench to Bedside.
The University of Kansas Cancer Center, January 20, 2019 Tune in February 20, 2019 as KU Cancer Center director Roy Jensen, MD, will host Steven Soper, PhD, KU [Read More...]
BioFluidica Applying Liquid Biopsy to Detect Leukemia While Reducing Biopsies
genomeweb | By John Gilmore, January 17, 2019 NEW YORK (GenomeWeb) – Fresh off being awarded several grants by the National Institutes of Health, startup BioFluidica has [Read More...]
In Promise of True Liquid Biopsy for Cancer, Chip Company BioFluidica® Awarded $1.7 Million by National Cancer Institute/National Institutes of Health for Clinical Trial in Children with Acute Lymphoblastic Leukemia
PR Newswire, January 10, 2019 SAN DIEGO /PRNewswire/ -- BioFluidica, a privately held cancer diagnostics company, has been awarded an SBIR Phase II National Institutes of Health grant [Read More...]
San Diego Blood Chip Maker BioFluidica Awarded Two NIH/NCI Grants for Isolation of Cell-Free DNA and Exosomes on Its Single Liquid Biopsy Platform
PR Newswire, January 07, 2019 SAN DIEGO /PRNewswire/ -- BioFluidica, a privately held cancer diagnostics company, has been awarded two separate SBIR Phase I NIH grants, the first [Read More...]